Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards Lifesciences

This article was originally published in The Gray Sheet

Executive Summary

Cardiac surgeons favor bovine pericardial tissue valves over porcine, the firm says. Edwards credits thePerimount stented bovine pericardial tissue valve for its 14.2% Cardiac Surgery sales growth in the first quarter. "Our pericardial valves have increasingly become the valve of choice for even younger patients due to their significant quality of life advantages," CEO Michael Mussallem explains during an April 22 earnings call. Separately, St. Jude believes FDA could approve a PMA for its BioCor stented porcine tissue valve by year-end (1"The Gray Sheet" Feb. 10, 2003, p. 19)...
Advertisement

Related Content

Advertisement
UsernamePublicRestriction

Register

MT018272

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel